TRIM-EDICINE

TRIM-edicine is an rapid growing, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of unmet medical needs, including oral healthcare, dermal wounds, ischemia/reperfusion injury, sports medicine and muscular dystrophy. The company is built around a core of novel proteins with remarkable biological properties. These unique proteins target a variety of cellular pathways that are altered in numerous disease states... We are a US biotech company focused on restoring cell health and resilience, with profound initial indications for the treatment of cancers and rare diseases, the protection of multiple organ injuries, and the effective reversal of aging.

Also known as: TRIM-edicine, Inc.

Primary location: Columbus United States